🔎 Trials Near Me

홈 › 삼중음성 유방암 › 텍사스

텍사스의 삼중음성 유방암 임상 시험

삼중음성 유방암 관련 연구 59개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

  • University of Texas Medical Branch, Galveston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03606967

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

  • UT MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05111561

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • NEXT Austin, Austin
  • START Center for Clinical Research, Fort Worth
  • University of Texas MD Anderson Cancer Center, Houston
  • 외 2개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  • Texas Oncology - DFW ( Site 8007), Dallas
  • Texas Oncology - West Texas ( Site 8004), El Paso
  • Kelsey-Seybold Clinic - North Houston Campus ( Site 0096), Houston
  • 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06841354

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Texas Oncology - DFW ( Site 8009), Dallas
  • UT Southwestern ( Site 0092), Dallas
  • Texas Oncology - Northeast Texas ( Site 8002), Flower Mound
  • 외 6개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06966700

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

  • NEXT Texas LLC - Austin, Austin
  • START Dallas Fort Worth, LLC, Fort Worth
  • MD Anderson, Houston
  • 외 4개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07503808

Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

  • START San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 여성 · 2026. 11. 9. 업데이트됨 · NCT07652242

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • NEXT Oncology, Austin
  • UT Southwestern, Dallas
피험자 모집 중1상
19세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06586957

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • University of Texas Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center - Conroe, Conroe
  • The University of Texas - M.D. Anderson Cancer Center, Houston
  • The University of Texas, MD Anderson Cancer Center - West Houston, Houston
  • 외 3개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07318805

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • Hendrick Medical Center ( Site 0117), Abilene
  • Harrington Cancer Center ( Site 0061), Amarillo
  • Texas Oncology - DFW ( Site 8000), Dallas
  • 외 9개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06393374

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University of Texas MD Anderson Cancer Center, Houston
  • South Texas Accelerated Research Therapeutics (START), San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06465069

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  • Texas Oncology, Austin
  • Texas Oncology, El Paso
  • MD Anderson Cancer Center, Houston
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05633654

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Texas Oncology, Abilene
  • Texas Oncology - Central / South Texas, Austin
  • Mary Crowley Cancer Research, Dallas
  • 외 3개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • The University of Texas - MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

Study of XB010 in Subjects With Solid Tumors

  • NEXT Austin, Austin
  • Baylor University Medical Center, Dallas
  • University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06545331

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07705334

Intratumoral N17350 in Advanced Solid Tumors

  • The University of Texas MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07339176

SMP-3124LP in Adults With Advanced Solid Tumors

  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 15. 업데이트됨 · NCT06526819

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

  • MD Anderson Cancer Center /ID# 255131, Houston
  • Univ Texas HSC San Antonio /ID# 257708, San Antonio
  • South Texas Accelerated Research Therapeutics /ID# 260404, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06084481

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

  • MD Anderson Cancer Center, Houston
  • NEXT Oncology, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06799065

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

  • Baylor University Medical Center, Baylor Charles A Sammons Cancer Center, Dallas
피험자 모집 중초기 1상
18세 이상 · 여성 · 2026. 10. 13. 업데이트됨 · NCT06008275

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07749586

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Houston
  • Research Site, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07115043

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • New Experimental Therapeutics - NEXT Oncology, Austin
  • Texas Oncology, Bedford
  • UT Southwest Simmons Cancer Center, Dallas
  • 외 2개
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

  • MD Anderson Cancer Center, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07189871

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Dallas
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

  • M D Anderson Cancer Center, Houston
피험자 모집 중
30세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT02945579

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • NEXT Oncology - Irving, Irving
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06618287

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Oncology Consultants, P.A., Houston
  • University of Texas M.D. Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

  • Baylor College of Medicine, Houston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07340541

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

  • MD Anderson Cancer Center, Houston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07020117

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • NEXT Oncology Austin, Austin
  • NEXT Oncology - Dallas, Irving
  • NEXT Oncology - San Antonio, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT06657222

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • UT Health Houston, Houston
피험자 모집 중관찰 연구
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07211178

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Dallas
  • Normunity Investigational Site, Houston
  • Normunity Investigational Site, San Antonio
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07182149

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  • Houston Methodist Hospital, Houston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT04895709

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

  • START San Antonio, San Antonio
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 13. 업데이트됨 · NCT05985655

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

  • Texas Oncology - Central/South Texas, Austin
  • Texas Oncology - West Texas, El Paso
  • Texas Oncology - Northeast Texas, Flower Mound
  • 외 1개
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06926868

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

  • Uni Of TX MD Anderson Cancer Cntr, Houston
피험자 모집 중1상
18세 ~ 100세 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT06562192

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
  • UT Southwestern Medical Center - Redbird, Dallas
  • Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
  • 외 8개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT05208762

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.